Página 3 - Melhores Cancro do fígado estádio 2 médicos - TOP-86 médicos

O Professor Associado Dr. Yusuf Acikgoz traz conhecimentos especializados em Oncologia Médica, com formação na Ohio State University e envolvimento ativo em ensaios clínicos internacionais.

• Participar em ensaios de Fase III como CheckMate-649 e Fortitude-101
• Ser membro da ASCO e da Sociedade Turca de Oncologia Médica
• Formar-se em imuno-oncologia através de cursos do CECOG em Viena
• Ser certificado em Boas Práticas Clínicas e Proteção de Seres Humanos

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais, tratando doentes no Hospital Universitário Istinye Liv.

• Especialista em Medicina Interna com experiência em vários hospitais na Turquia
• Oncologista na Clínica de Oncologia de Ancara e no Hospital Regional de Formação e Investigação de Erzurum
• Estudos de medicina na Universidade de Selcuk, em Konya
• Promoção a Professor Associado em 2016

Médica-chefe em um centro de oncologia interdisciplinar certificado, a Dra. Viola Fox é especialista em tratamentos inovadores para o câncer de fígado. Suas pesquisas em biologia molecular impulsionaram as terapias oncológicas.

• Especializar-se em quimioterapia, imunoterapia e terapias-alvo
• Qualificar-se como especialista em genética com foco em oncologia
• Atuar como membro ativo da American Association for Cancer Research

O Professor Keil é especialista em radiologia diagnóstica e intervencionista, com foco em exames de imagem e intervenções para cancro do fígado no Hospital Académico de Solingen.

• Licenciar-se com distinção pela Universidade Julius-Maximilian de Würzburg
• Formar-se sob a orientação do renomado Professor Rolf W. Günther em Aachen
• Ser especialista em técnicas modernas de imagem como ressonância magnética, tomografia computarizada e ecografia
• Ser médico-chefe da Clínica de Radiologia Diagnóstica e Intervencionista desde 2022

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O Prof. Associado Nail Paksoy é um oncologista médico certificado pela ESMO no Hospital Medipol Bahçelievler, especializado em cancro do fígado com vasta experiência em ensaios clínicos.

• Concluir a bolsa de especialização no Instituto de Oncologia da Universidade de Istambul
• Atuar como subinvestigador em 8 ensaios clínicos internacionais de oncologia
• Publicar múltiplos estudos sobre a eficácia do tratamento do cancro
• Especializar-se em abordagens de tratamento personalizadas

O Dr. Auala Hubert lidera o Centro de Cancro Gastrointestinal do Hadassah Medical Center, contando com 33 anos de experiência focada em oncologia.

• Especializar-se em Oncologia Médica e Radioterapia
• Chefe do Centro de Cancro Gastrointestinal no Hadassah
• Certificado em Oncologia e Radioterapia
• Membro da Sociedade de Oncologia Clínica de Israel
• Fluente em inglês e hebraico para pacientes internacionais

Especializado em cirurgia laparoscópica e oncológica com formação na Universidade de Istambul. O Dr. Al foca-se em técnicas minimamente invasivas para o cancro do fígado.

• Formar-se em cirurgia laparoscópica avançada na Faculdade de Medicina de Cerrahpaşa
• Realizar cirurgias bariátricas e anti-refluxo laparoscópicas
• Licenciar-se pela Faculdade de Medicina da Universidade Ondokuz Mayıs
• Especializar-se na Faculdade de Medicina da KTÜ, Hospital Farabi

O Professor Associado Babek Tabandeh é um cirurgião especialista em cancro do fígado e técnicas minimamente invasivas. Realiza cirurgias hepáticas complexas no Hospital Medical Park Göztepe.

• Mais de 25 anos de experiência em cirurgia geral e oncológica
• Foco na cirurgia minimamente invasiva para uma melhor recuperação
• Autor publicado com mais de 40 artigos científicos
• Membro do conceituado American College of Surgeons
• Também detém a filiação na Liver Transplantation Society

O Dr. Ozden traz mais de 20 anos de experiência em oncologia, aperfeiçoada através de diversos cargos clínicos em toda a Turquia.

• Especializado em oncologia médica com foco em cancro do fígado
• Formado na renomada Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Vasta experiência em ambientes hospitalares privados e universitários
• Comprometido com planos de tratamento personalizados para cada paciente

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Especializada em viroterapia – um dos mais novos campos da imunologia – a Dra. Jaunalksne traz mais de 30 anos de experiência ao tratamento do cancro do fígado.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna
• Focar em abordagens imunológicas de ponta para o cancro

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).